Fixed-Dose-Rate Gemcitabine Infusion in Patients with Advanced Pancreatic or Biliary Tree Adenocarcinoma

20107 citationsJournal Article

Authors

Joan Manel Mañé · Hospital de Cruces

Aintzane Sancho · Hospital de Cruces

Alberto Múñoz · Hospital de Cruces

Itziar Rubio · Hospital de Cruces

Ricardo Fernández · Hospital de Cruces

Sergio Carrera · Hospital de Cruces

N. Fuente ·

Abstract

Fixed-dose-rate gemcitabine has a relevant antitumor activity but with significant toxicity. It represents an interesting schedule and could be combined with other biological or chemotherapeutic agents.

Topics & Keywords

Pancreatic and Hepatic Oncology Research Cholangiocarcinoma and Gallbladder Cancer Studies Cancer Genomics and Diagnostics

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Tumori Journal

Volume 96, Issue 3, pp. 405-410

DOI: 10.1177/030089161009600305

Field-Weighted Citation Impact: 0.59